Abstract
Dyslipidemia is an emerging disease in China, especially in the presence of hypertension and diabetes mellitus. We investigated the association of dyslipidemia with the use of antihypertensive and antidiabetic agents. The study participants (n = 2423) were hypertensive and diabetic patients enrolled in a China nationwide registry. Serum mean ± (SD, except for serum triglycerides, median [interquatile range]) concentrations were 1.38 (0.97-2.02) mmol/L, 4.85 ± 1.12 mmol/L, 1.30 ± 0.36 mmol/L, and 2.89 ± 0.92 mmol/L for triglycerides and total, high-density lipoprotein (HDL), and low-density lipoprotein (LDL) cholesterol, respectively. The prevalence of dyslipidemia was 18.9%, 13.5%, 16.6%, and 37.7% for hypertriglyceridemia (serum triglycerides ≥2.3 mmol/L), hypercholesterolemia (total cholesterol ≥6.2 mmol/L or LDL cholesterol ≥4.1 mmol/L), low HDL cholesterol (HDL cholesterol <1.0 mmol/L), and any of the three lipid disorders, respectively. Treated (n = 1647), compared with untreated hypertensive patients (n = 303), had a significantly (P ≤ .0006) lower serum total, LDL, and HDL cholesterol, but similar serum triglycerides (P = .20). Treated (n = 1325), compared with untreated diabetic patients (n = 238), had a significantly (...Continue Reading
References
Aug 1, 1994·Hypertension·S W RabkinS G Carruthers
Jan 20, 2000·The New England Journal of Medicine·UNKNOWN Heart Outcomes Prevention Evaluation Study InvestigatorsG Dagenais
Apr 9, 2002·Lancet·Björn DahlöfUNKNOWN LIFE Study Group
Jun 18, 2002·European Journal of Internal Medicine·Christian GeltnerJosef R. Patsch
Dec 20, 2002·JAMA : the Journal of the American Medical Association·UNKNOWN ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatm
May 17, 2005·Cardiovascular Diabetology·Cristiana VitaleGiuseppe M C Rosano
Sep 13, 2005·Lancet·Björn DahlöfUNKNOWN ASCOT Investigators
Dec 7, 2005·Journal of Hypertension·Giuseppe ManciaAlberto Zanchetti
Feb 2, 2006·Diabetes, Obesity & Metabolism·J A DavidsonUNKNOWN Pioglitazone 343 Study Group
Jun 12, 2010·Diabetes Research and Clinical Practice·Ulrich KintscherThomas Unger
Jun 23, 2011·JAMA : the Journal of the American Medical Association·David PreissKausik K Ray
Nov 1, 2011·Current Atherosclerosis Reports·Roderick Deano, Matthew Sorrentino
Jun 9, 2016·Journal of Hypertension·Jie SongUNKNOWN ATTEND Investigators
Jun 16, 2017·The Lancet. Diabetes & Endocrinology·John R PetrieUNKNOWN REMOVAL Study Group
Jan 17, 2020·The Journal of Clinical Hypertension·Wei ZhangUNKNOWN ATTEND investigators
May 7, 2020·Hypertension·Thomas UngerAletta E Schutte